Abstract

Though rare, scrotal erythema can be a specific clue in patients being treated with Cabozantinib and should be considered when faced with this unique rash which may be under-recognised by dermatologists.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call